Vancouver, British Columbia–(Newsfile Corp. – January 29, 2021) – Harvest One Cannabis Inc. (TSXV: HVT) (OTCQX: HRVOF) (“Harvest One” or the “Company“), a uniquely positioned cannabis-infused CPG company, announced today that its LivRelief CBD cream achieved the #1 revenue position within the Infused Topicals category in Ontario based on Ontario Cannabis Store (“OCS“) sales data, as of December 2020 (the “OCS Sales Data“).
The Company’s LivRelief CBD cream was the top-selling SKU in the Infused Topicals category in Ontario for the six-month period ended December 2020, by dollars sold, based on OCS Sales Data. In addition, for the same period, the Company’s LivRelief brand captured approximately 32% market share within the Infused Topicals category in Ontario based on sales revenue. 1
“We are very pleased to be ranked as the #1 selling infused topical in the Ontario market,” said Gord Davey, President and Chief Executive Officer of Harvest One. “Our innovative infused topical with its effective and differentiated delivery system has resonated well with consumers, and established itself as the leader in the Infused Topicals category. We will continue to educate the market on this category and look forward to building on this success with a number of new innovative product formats and line extensions in 2021.”
LivRelief Infused Topicals
To view an enhanced version of this image, please visit:
https://orders.newsfilecorp.com/files/2413/73111_1f823d4734e91970_001full.jpg
LivRelief’s infused products are available nationally through Medical Cannabis by Shoppers™, as well as in cannabis stores throughout Ontario, British Columbia, Alberta, Saskatchewan, Manitoba and New Brunswick. Additional provincial distribution agreements are expected shortly.
LivRelief’s infused topicals are currently available in two formats – a CBD-only formulation containing 250mgs of CBD and a 1:1 format formulation with 125mgs of THC and 125mgs of CBD.
About Harvest One
Harvest One is global CPG company that develops and distributes premium health, wellness and selfcare products with a market focus on sleep, pain, and anxiety. Harvest One is a uniquely positioned company in the cannabis space with a focus on cannabis-infused and non-infused consumer packaged goods. Harvest One owns and operates three subsidiaries; Dream Water Global, LivRelief (consumer) and Satipharm (medical and nutraceutical). For more information, please visit www.harvestone.com.
Cautionary Note Regarding Forward-Looking Statements
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance about Harvest One and its business and operations, which include, among other things, its corporate strategy moving forward, and future opportunities available for the Company. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. The forward-looking information contained in this press release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.
Investor Relations:
Colin Clancy
Investor Relations
[email protected]
1-877-915-7934
Notes
1 Data cited is based on sales information provided by OCS.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/73111